Author'S reply
- PMID: 24707360
- PMCID: PMC3974497
- DOI: 10.5173/ceju.2013.03.art4
Author'S reply
References
-
- Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63:521–527. - PubMed
-
- Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobialresistant pathogens associated with healthcare–associated infections: annual summary of data reported to the National Health– care Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29:996–1011. - PubMed
-
- Wills ML, Hamper UM, Partin AW, Epstein JI. Incidence of high–grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology. 1997;49:367–373. - PubMed
-
- Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M. Careful selection and close monitoring of low–risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol. 2010;58:831–835. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources